| Liwing, Johan (XNK Therapeutics 202203 CEO before JnJ + Roche) |
Chief Executive Officer (CEO) |
XNK Therapeutics AB |
Sweden |
| Ljunggren, Isabelle (Cellink 202105 Head of Communications) |
Public Relations Manager / Investor Relations Manager |
Bico (Group) |
Sweden |
| Llewellyn, Chris (Schauenburg 201912 Asia Pacific Sales Manager at Markes 201406 Global Channel Manager) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Llobet, Manuel (Allergy Therapeutics 201709 CEO) |
Chief Executive Officer (CEO) |
Allergy Therapeutics (Group) |
United Kingdom (GB) |
| Lloyd-Harris, Genghis (Abingworth 201402 Partner) |
Partner (venture partner) |
Carlyle (Group) |
United Kingdom (GB) |
| Lo, Richard (Techcomp 201411 CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
China |
| Loa, Alexander (acCELLerate GmbH 201605 Managing Director) |
Managing Director |
Accellerate GmbH |
Germany |
| Lobacki, Joseph (Artax Biopharma 202005– CEO before Verastem + Finch Therapeutics + Medivation + Micromet + Genzyme) |
Chief Executive Officer (CEO) |
Artax Biopharma Inc. |
United States (USA) |
| Lochter, André (atugen 2003– before Nordic Bioscience) |
n. a. |
Silence Therapeutics (Group) |
Germany |
| Locker, Susanne (LISAvienna 201310 Project Manager Marketing + PR) |
Sales Manager / Marketing Manager |
Austria (govt) |
Austria |
| Lockhoff, Oswald (Sidanis Pharma 201102– Managing Director + Founder before Consultant before Bayer) |
Managing Director |
Sidanis Pharma GmbH |
Germany |
| Lockl, Jannik (inContAlert 202309 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
inContAlert GmbH |
Germany |
| Lockwood, Jeff (Bayer 202205 VP Corporate Communications at BlueRock Therapeutics) |
Public Relations Manager / Investor Relations Manager |
Bayer (Group) |
United States (USA) |
| Loeb, Gary H. (Sangamo 201907– EVP + General Counsel before Achaogen + Amyris + Genentech) |
General Counsel / Chief Legal Officer (CLO) |
Sangamo (Group) |
United States (USA) |
| Loehr, Achim (CureVac 201710 Head Business Development) |
Business Development Manager / Strategy Manager |
CureVac (Group) |
Germany |
| Loescher, Peter (Siemens 200705– CEO before Merck & Co) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Loeser, Thomas (Tom) (T-Curx 202212– CFO + Viopas Venture Consulting 202211– Managing Partner) |
Chief Financial Officer (CFO) |
T-Curx GmbH |
Germany |
| Lofton-Day, Catherine (Epigenomics 200607 VP Molecular Biology, Diagnostics) |
n. a. |
Epigenomics (Group) |
Germany |
| Loftsson, Thorsteinn (Oculis ehf 201608 Co-Founder) |
Company Founder |
Oculis (Group) |
Iceland |
| Loh, Phoebe (Qiagen 202108 Senior Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Qiagen (Group) |
Germany |
| Lohfink, Martin (up to data 201003 Managing Director) |
Managing Director |
up to data professional services GmbH |
Germany |
| Lohmann, Charlotte (MorphoSys 201205– General Counsel before Wilex SVP Legal Affairs + Human Resources before KPMG) |
General Counsel / Chief Legal Officer (CLO) |
MorphoSys (Group) |
Germany |
| Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Germany |
| Lohmeier, Uwe (Campus Berlin-Buch 202305 Head of Gläsernes Labor Akademie) |
n. a. |
Campus Berlin-Buch GmbH |
Germany |
| Lohmer, Stefan (Axxam 200807 CEO) |
Chief Executive Officer (CEO) |
Axxam S.p.A. |
Italy |
| Lohoff, Tim (Forbion 202210 Analyst) |
Analyst (Financial / Industry) |
Forbion (Group) |
Germany |
| Lohrisch, Hans-Joachim (Altana Pharma 200607 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Germany |
| Lohrmann, Marc (Vesalius Biocapital 202001 Managing Partner at Vesalius Biocapital III) |
Managing Partner (investment firm) |
Vesalius Biocapital (Group) |
Luxembourg |
| Lohse, Axel (Germany (govt) 201611 Manager Biotech + Pharma at GTAI) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Loibner, Hans (Apeiron Biologics 200810–201807 CEO RETIRED 7/18 continues as senior advisor) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Loiret-Bernal, Cédric (GeneProt 200009 CEO) |
Chief Executive Officer (CEO) |
GeneProt Inc. |
Switzerland |
| Lokey, Houlihan |
consulting (economic) |
|
|
| London, Jeff (Midwest Biosolutions 202305) |
Chief Executive Officer (CEO) |
Midwest Biosolutions Corporation |
United States (USA) |
| Longchamp, Pascal (Evolva 201201–201712 CBO TO STEP DOWN unitl end 2017) |
Chief Business Officer (CBO) |
Evolva (Group) |
Switzerland |
| Longwell, Lance (Siemens 202104 Director of Communications + PR at Siemens Healthineers) |
Public Relations Manager / Investor Relations Manager |
Siemens (Group) |
Germany |
| Lonnen, Rana (Novartis 202009 Stragetic Venture Capital at Novartis Pharma) |
Investment Manager |
Novartis (Group) |
Switzerland |
| Looi, Liew Yew (Nycomed 201011 SVP North Asia) |
Regional manager |
Takeda (Group) |
Switzerland |
| Loose, Achim (Nordantec GmbH 200902 Managing Director) |
Managing Director |
Nordantec GmbH Norddeutsche Analytik und Messtechnik |
Germany |
| Lopata, Michael (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
| Lopes-Fernandes, Philippe (Ipsen 202010– EVP + CBO based in US before Merck KGaA) |
Chief Business Officer (CBO) |
Ipsen (Group) |
France |
| Lopez Belda, Antonio (Biofrontera 201503– Marketing Manager at Biofrontera Spain before Allergan Pharmaceuticals) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Spain (España) |
| Lopriore, Stefano (STMicroelectronics 200506) |
n. a. |
STMicroelectronics (Group) |
Switzerland |
| Lorenz, Fabian (MC Services 201504– Senior Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Lorenz, Martin (Platomics 201908 Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Platomics GmbH |
Austria |
| Lorenz, Michael (Univ Bremen + Molzym) |
Managing Director |
Molzym GmbH & Co. KG |
Germany |
| Lorenz, Noah M. (Mementor 202208 Managing Director + Co-Founder) |
Managing Director |
ResMed (Group) |
Germany |
| Lorenz, Sarah (Univ München 202004 Director Business Development at German Entrepreneurship GmbH) |
Business Development Manager / Strategy Manager |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Los, Georgyi (Leica 200808 Lead Scientist Imaging Products) |
n. a. |
Danaher (Group) |
Germany |
| Loshbaugh, Amanda (ADC Therapeutics 202301 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
ADC Therapeutics (Group) |
Switzerland |
| Loss, Christian (Neopharm 201502 Managing Director of Neovii Biotech GmbH) |
Managing Director |
Neopharm (IL) (Group) |
Germany |
| Lossau, Harald |
n. a. |
FRIZ Biochem GmbH |
Germany |
| Lott, Josef (Eppendorf 202308 Product Manager) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Lotter, Mark G. (Nuance Pharma 202203 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nuance Pharma (CN, Shanghai) |
China |
| Lottspeich, Friedrich (MPI 1993) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Lotz, Julian (Biovox 202204 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Biovox GmbH |
Germany |
| Loughlin, Rose (Moderna 202309 SVP for Research + Early Development) |
Research & Development Manager |
Moderna (Group) |
United States (USA) |
| Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) |
Chief Executive Officer (CEO) |
ObsEva (Group) |
Switzerland |
| Love, Douglas (Doug) (Annexon Biosciences 201812 CEO) |
Chief Executive Officer (CEO) |
Annexon Inc. (ANNX) |
United States (USA) |
| Loven, Jakob (Nextech Invest 201904 Partner) |
Partner (venture partner) |
Nextech (Group) |
Switzerland |
| Loveridge, Jason (4SC 201609– CEO) |
Chief Executive Officer (CEO) |
4SC (Group) |
Germany |
| Lowenstein, Inese (Danaher 202104– Senior Talent Adivsor before 201709– President Sciex joined 8/16 before Merck KGaA) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Lowery, Tim (JSR Corp 202205 President of JSR Life Sciences) |
President/Director/Head Business Group/Unit/Division |
JSR Corporation (Group) |
Japan |
| Lowinger, Timothy B. (Mersana Therapeutics 201406 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mersana Therapeutics Inc. (Nasdaq: MRSN) |
United States (USA) |
| Loy, André (Stratec 201107 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Stratec (Group) |
Germany |
| Loy, Spike (BVF Partners 202105 Managing Director) |
Managing Director |
BVF Partners L.P. (Biotechnology Venture Fund) |
United States (USA) |
| Lu, Patrick (Sirnaomics 202107 CEO + Founder before Novartis + Digene + Intradigm) |
Chief Executive Officer (CEO) |
Sirnaomics (Group) |
United States (USA) |
| Lubenau, Heinz (Vaximm 201101 Managing Director Vaximm GmbH before BioGeneriX before Servier) |
Managing Director |
Vaximm (Group) |
Germany |
| Lubenow, Helge (Proteomedix 202001– CEO before Consultant before 1997–2015 at Qiagen) |
Chief Executive Officer (CEO) |
Proteomedix AG |
Switzerland |
| Lubert, Wolfgang (EnjoyVenture Management GmbH 201003 Managing Director [CEO]) |
Managing Director |
EnjoyVenture (Group) |
Germany |
| Lucas, Svetlana (Tizona Therapeutics 201510 VP Business Development) |
Business Development Manager / Strategy Manager |
Tizona Therapeutics Inc. |
|
| Luchinat, Claudio (Univ Florence 201706 Professor + Co-Founder of Magnetic Resonance Center (CERM)) |
Professor |
University of Florence |
Italy |
| Lucier, Gregory T. (NuVasive 201505– CEO before CEO of Life Technologies + Invitrogen 2003–2014) |
Chief Executive Officer (CEO) |
NuVasive (Group) |
United States (USA) |
| Lucke, Marc-Olivier (Atlantic Labs Manager GmbH 201909) |
n. a. |
Atlantic Labs Manager GmbH |
Germany |
| Ludemann-Hombourger, Olivier (PolyPeptide 202305 Director Global Innovation + Technology) |
President/Director/Head Business Group/Unit/Division |
PolyPeptide (Group) |
Switzerland |
| Ludwig, Jutta (Eckert & Ziegler 202305 Management Board Member) |
Board member, executive |
Eckert & Ziegler (Group) |
Germany |
| Ludwig, Matthias (Endress+Hauser 201705 Life Science Applications Specialist at Analytik Jena) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Ludwig, Petra (Technologiepark Warnemünde 201103 Managing Director) |
Managing Director |
Technologiepark Warnemünde GmbH (TPW) |
Germany |
| Lues, Inge (Probiodrug 201410–201810 Chief Developm Offficer RETIRED 10/18 before Merck KGaA 1998–2007) |
Research & Development Manager |
Vivoryon (Group) |
Germany |
| Luider, Theo (Erasmus Univ 201206 Head of Laboratories of Neuro-Oncology at Dept of Neurology at EMC) |
Laboratory Manager (university / research institute) |
Erasmus University Rotterdam |
Netherlands |
| Lukesch, Michael (Valanx Biotech 202311 CEO + Founder) |
n. a. |
|
|
| Luly, Jay R. (Enanta Pharmaceuticals 201202 CEO) |
Chief Executive Officer (CEO) |
Enanta Pharmaceutcials Inc. |
United States (USA) |
| Lun, Klaus (Tecan 201612– promoted to Head of Life Sciences joined 201306 before Molecular Devices + Leica Microsystems) |
President/Director/Head Business Group/Unit/Division |
Tecan (Group) |
Switzerland |
| Lundberg, Bill (Merus 202001– CEO formerly CRISPR Therapeutics + Alexion + Taligen) |
Chief Executive Officer (CEO) |
Merus (Group) |
Netherlands |
| Lundberg, Jan M. (Lilly 201003– EVP Science + Technology before AstraZeneca EVP Global Discovery Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Lundemose, Anker (Mission Therapeutics 201501– CEO before Bionor Pharma + OSI Pharma + Prosidion + Novo Nordisk) |
Chief Executive Officer (CEO) |
Mission Therapeutics Ltd. |
United Kingdom (GB) |
| Luo, Jiali (Boehringer 201801 General Manager of Boehringer Ingelheim Biopharmaceuticals (China) Co Ltd) |
General Manager (management) |
Boehringer Ingelheim (Group) |
China |
| Luo, Peizhi (Peter) (Adagene 201904 CEO + Founder before Abmaxis) |
Chief Executive Officer (CEO) |
Adagene (Group) |
United States (USA) |
| Luria, Xavier (AMP BIosimilars 201504 Scientific Board Member + former Head of Medicines Safety + Efficacy at EMA) |
Board member, non-executive |
AMP Biosimilars AG |
Germany |
| Luscombe, Caroline (Sanofi 201810– Head of Human Resources before LafargeHolcim + Syngenta + GE + Amersham) |
Human Resources Manager |
Sanofi (Group) [since May 2011] |
France |
| Lusser, Markus B. (Danaher 201507– President Leica Microsystems before VP Global Sales AB Sciex) |
Managing Director |
Danaher (Group) |
Germany |
| Luther, Rolf (Fuchs Petrolub 201409 Head of Advanced Development) |
Research & Development Manager |
Fuchs Petrolub (Group) |
Germany |
| Lutz, Michael (HepaRegenix 201910– Managing Director (CEO) before LifeCodexx + Clinical Data/Cogenics + Epidauros) |
Managing Director |
HepaRegenix GmbH |
Germany |
| Lutz, Phillipe (Telormedix 201005– CFO before Synosia Therapeutics CFO before Credit Suisse) |
Chief Financial Officer (CFO) |
Telormedix S.A. |
Switzerland |
| Lutz, Regina (MC Services 202209) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Lübbert, Hermann (Biofrontera 200311 CEO) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
Germany |
| Lübke, Julian (Cubuslab 201905 HeadProduct + Co-Founder) |
Product Manager (personnel) |
Labforward (Group) |
Germany |
| Lücke, Klaus (Gilupi GmbH 2006–201605 Managing Director + Founder LEFT 5/16) |
Managing Director |
Viroad (Group) |
Germany |
| Lüdke, Gerd (Curetis 201310 Director Bio-Assay Development) |
Research & Development Manager |
OpGen (Group) |
Germany |
| Lührs, Renke (Buse Heberer Fromm 201508 + DBI AG 201508 Supervisor Board Member) |
Attorney / Lawyer |
Buse Heberer Fromm Rechtsanwälte |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 45 46 47 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
